Literature DB >> 35896092

Low temperature hybrid 3D printing of hierarchically porous bone tissue engineering scaffolds within situdelivery of osteogenic peptide and mesenchymal stem cells.

Jiahui Lai1, Chong Wang2,3, Jia Liu4, Shangsi Chen1, Chaoyu Liu5, Xiangxuan Huang6, Jing Wu2, Yue Pan7, Yuancai Xie8, Min Wang1.   

Abstract

Compared to other conventional scaffold fabrication techniques, three-dimensional (3D) printing is advantageous in producing bone tissue engineering scaffolds with customized shape, tailored pore size/porosity, required mechanical properties and even desirable biomolecule delivery capability. However, for scaffolds with a large volume, it is highly difficult to get seeded cells to migrate to the central region of the scaffolds, resulting in an inhomogeneous cell distribution and therefore lowering the bone forming ability. To overcome this major obstacle, in this study, cell-laden bone tissue engineering scaffolds consisting of osteogenic peptide (OP) loadedβ-tricalcium phosphate (TCP)/poly(lactic-co-glycolic acid) (PLGA) (OP/TCP/PLGA, designated as OTP) nanocomposite struts and rat bone marrow derived mesenchymal stem cell (rBMSC)-laden gelatin/GelMA hydrogel rods were produced through 'dual-nozzle' low temperature hybrid 3D printing. The cell-laden scaffolds exhibited a bi-phasic structure and had a mechanical modulus of about 19.6 MPa, which was similar to that of human cancellous bone. OP can be released from the hybrid scaffolds in a sustained manner and achieved a cumulative release level of about 78% after 24 d. rBMSCs encapsulated in the hydrogel rods exhibited a cell viability of about 87.4% right after low temperature hybrid 3D printing and could be released from the hydrogel rods to achieve cell anchorage on the surface of adjacent OTP struts. The OP released from OTP struts enhanced rBMSCs proliferation. Compared to rBMSC-laden hybrid scaffolds without OP incorporation, the rBMSC-laden hybrid scaffolds incorporated with OP significantly up-regulated osteogenic differentiation of rBMSCs by showing a higher level of alkaline phosphatase expression and calcium deposition. This 'proof-of-concept' study has provided a facile method to form cell-laden bone tissue engineering scaffolds with not only required mechanical strength, biomimetic structure and sustained biomolecule release profile but also excellent cell delivery capability with uniform cell distribution, which can improve the bone forming ability in the body.
© 2022 IOP Publishing Ltd.

Entities:  

Keywords:  cell delivery; hydrogel; low temperature hybrid 3D printing; osteogenic peptide; tricalcium phosphate

Mesh:

Substances:

Year:  2022        PMID: 35896092     DOI: 10.1088/1758-5090/ac84b0

Source DB:  PubMed          Journal:  Biofabrication        ISSN: 1758-5082            Impact factor:   11.061


  1 in total

1.  Cryogenic 3D Printing of w/o Pickering Emulsions Containing Bifunctional Drugs for Producing Hierarchically Porous Bone Tissue Engineering Scaffolds with Antibacterial Capability.

Authors:  Xinliang Ye; Zhi He; Yuming Liu; Xiaoying Liu; Rouye He; Ganhang Deng; Ziqing Peng; Jiayu Liu; Zicai Luo; Xiaoling He; Xiang Wang; Jing Wu; Xiaowei Huang; Jingying Zhang; Chong Wang
Journal:  Int J Mol Sci       Date:  2022-08-27       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.